0001179110-14-017086.txt : 20141125 0001179110-14-017086.hdr.sgml : 20141125 20141125170819 ACCESSION NUMBER: 0001179110-14-017086 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20141121 FILED AS OF DATE: 20141125 DATE AS OF CHANGE: 20141125 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HOSPIRA INC CENTRAL INDEX KEY: 0001274057 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 275 FIELD DR CITY: LAKE FOREST STATE: IL ZIP: 60045 BUSINESS PHONE: 8479376472 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SMITH BRIAN J CENTRAL INDEX KEY: 0001288288 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31946 FILM NUMBER: 141250453 MAIL ADDRESS: STREET 1: 275 NORTH FIELD DRIVE STREET 2: DEPT NLEG, BLDG H1-4S CITY: LAKE FOREST STATE: IL ZIP: 60045 4 1 edgar.xml FORM 4 - X0306 4 2014-11-21 0 0001274057 HOSPIRA INC HSP 0001288288 SMITH BRIAN J C/O HOSPIRA, INC. 275 NORTH FIELD DRIVE LAKE FOREST IL 60045 0 1 0 0 SVP and Special Counsel Common Stock 2014-11-21 4 M 0 48300 32.470 A 100935 D CommonStock 2014-11-21 4 S 0 48300 59.340 D 52635 D Common Stock 2014-11-21 4 M 0 1300 41.900 A 53935 D Common Stock 2014-11-21 4 S 0 1300 59.134 D 52635 D Common Stock 2014-11-24 4 M 0 1700 32.47 A 54335 D Common Stock 2014-11-24 4 S 0 1700 59.000 D 52635 D Common Stock 2014-11-24 4 M 0 33700 41.90 A 86335 D Common Stock 2014-11-24 4 S 0 33700 59.305 D 52635 D Common Stock 2014-11-24 4 M 0 38000 43.18 A 90635 D Common Stock 2014-11-24 4 S 0 38000 59.019 D 52635 D Common Stock 2014-11-24 4 M 0 62700 22.150 A 115335 D Common Stock 2014-11-24 4 S 0 62700 59.482 D 52635 D Common Stock 9707 I See note 4. Stock Options (Right to Buy) 32.470 2014-11-21 4 M 0 48300 0 A 2015-05-08 Common Stock 48300 1700 D Stock Option (Right to Buy) 41.90 2014-11-21 4 M 0 1300 0 A 2016-05-16 Common Stock 1300 33700 D Stock Options (Right to Buy) 32.470 2014-11-24 4 M 0 1700 0 A 2015-05-08 Common Stock 1700 0 D Stock Options 41.900 2014-11-24 4 M 0 33700 0 A 2016-05-16 Common Stock 33700 0 D Stock Options 43.180 2014-11-24 4 M 0 38000 0 A 2015-03-05 Common Stock 38000 0 D Stock Options (right to buy) 22.150 2014-11-24 4 M 0 62700 0 A 2016-03-04 Common Stock 62700 0 D The stock options, granted on May 9, 2005, vested in three equal installments on May 9, 2006, 2007, and 2008. The exercise price of $32.470 is the average of the high and low trading prices of Hospira common stock on the date of grant. The stock options have a seven-year term, and expire on May 8, 2015. Exercise of derivative security exempted pursuant to Rule 16b-3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.00 to $59.48, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range of prices set forth in this footnote. Balance in the qualified Hospira 401(k) Retirement Savings Plan, as of November 25, 2014. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.13 to $59.14, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range of prices set forth in this footnote. The stock options, granted on May 17, 2006, vested in three equal installments on May 17, 20067 2008, and 2009. The exercise price of $41.900 is the average of the high and low trading prices of Hospira common stock on the date of grant. The stock options have a seven-year term, and expire on May 16, 2016. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.24 to $59.58, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range of prices set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.00 to $59.16, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range of prices set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.40 to $59.51, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range of prices set forth in this footnote. The stock options, granted on March 6, 2008, vested in three equal installments on March 6, 2009, 2010, and 2011. The exercise price of $43.180 is the average of the high and low trading prices of Hospira common stock on the date of grant. The stock options have a seven-year term, and expire on March 5, 2015. The stock options, granted on March 5, 2009, vested in three equal installments on March 5, 2010, 2011, and 2012. The exercise price of $22.150 is the average of the high and low trading prices of Hospira common stock on the date of grant. The stock options have a seven-year term, and expire on March 4, 2016. Benjamin Kwakye, Attorney in Fact 2014-11-25